The Gruzman Lab Drug Development

Accessibility Accessibility

Benzyl-para-di-[5-methyl-4-(n-octylamino)pyrimidin-2(1H)one] as an Interferon beta (IFN-β) modulator.

Trifonov L.; Yurchenko M.; Skjesol A.; Cohen G.; Espevik T.; Korshin E. E.; Husebye H.;* Gruzman A., 2022

Molecular Diversity, 2022, 26: 2175–2188.